Remission of Diabetes Mellitus in Cats Cannot be Predicted by the Arginine Stimulation Test

Journal of Veterinary Internal Medicine

Volumn 25, Issue 1, 2011, Pages 83-89

  Tschuor, F ^a   Zini, E ^a   Schellenberg, S ^a   Wenger, M ^a   Kaufmann, K ^a   Furrer, D ^a   Lutz, T A ^a   Reusch, C E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Feline; Glucagon; Insulin; Normoglycemia

Indexed keywords

ARGININE; DIAGNOSTIC AGENT; FRUCTOSAMINE; GLUCAGON; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; NONPARAMETRIC TEST; PANCREAS ISLET BETA CELL; SECRETION;

ANIMALS; ARGININE; BLOOD GLUCOSE; CAT DISEASES; CATS; DIABETES MELLITUS; FEMALE; FRUCTOSAMINE; GLUCAGON; INSULIN; INSULIN-SECRETING CELLS; MALE; STATISTICS, NONPARAMETRIC;

FELIDAE;

EID: 78651257341     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0649.x     Document Type: Article

References (34)

1. Prahl A, Guptill L, Glickman NW, et al. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J Feline Med Surg 2007;9:351-358.
2. Baral RM, Rand J.S., Catt M.J., Farrow H.A. Prevalence of feline diabetes mellitus in a feline private practice. J Vet Intern Med 2003;17:433-434.
3. Hoenig M, Thomaseth K, Brandao J, et al. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol 2006;31:373-389.
4. Nelson RW, Griffey SM, Feldman EC, et al. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med 1999;13:28-35.
5. Bennett N, Greco DS, Peterson ME, et al. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. J Feline Med Surg 2006;8:73-84.
6. Alt N, Kley S, Tschuor F, et al. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007;83:331-335.
7. Rand J. Current understanding of feline diabetes: Part 1, pathogenesis. J Feline Med Surg 1999;1:143-153.
8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
9. Bardet S, Pasqual C, Maugendre D, et al. Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabetes Metab 1989;15:224-232.
10. Scheen AJ, Castillo MJ, Lefebvre PJ. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: Methodological aspects and clinical applications. Diabetes Metab 1996;22:397-406.
11. Utzschneider KM, Prigeon RL, Tong J, et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: Implications for research studies. Diabetologia 2007;50:2516-2525.
12. Ward WK, Bolgiano DC, McKnight B, et al. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984;74:1318-1328.
13. Druet C, Tubiana-Rufi N, Chevenne D, et al. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J Clin Endocrinol Metab 2006;91:401-404.
14. Drucker D, Zinman B. Pathophysiology of beta cell failure after prolonged remission of insulin-dependent diabetes mellitus (IDDM). Diabetes Care 1984;7:83-87.
15. Brandle M, Lehmann R, Maly FE, et al. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Care 2001;24:1253-1258.
16. Curry DL, Morris JG, Rogers QR, et al. Dynamics of insulin and glucagon secretion by the isolated perfused cat pancreas. Comp Biochem Physiol A 1982;72:333-338.
17. Kitamura T, Yasuda J, Hashimoto A. Acute insulin response to intravenous arginine in nonobese healthy cats. J Vet Intern Med 1999;13:549-556.
18. Ellingsgaard H, Ehses JA, Hammar EB, et al. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci USA 2008;105:13163-13168.
19. Alt N, Kley S, Haessig M, et al. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus. J Am Vet Med Assoc 2007;230:1011-1017.
20. Sieber-Ruckstuhl NS, Kley S, Tschuor F, et al. Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet Intern Med 2008;22:1326-1332.
21. Zini E, Osto M, Franchini M, et al. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009;52:336-346.
22. Furrer D, Kaufmann K, Reusch CE, et al. Amylin reduces plasma glucagon concentration in cats. Vet J 2010;184:236-240.
23. Stevenson RW, Steiner KE, Davis MA, et al. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes 1987;36:382-389.
24. Huypens P, Ling Z, Pipeleers D, et al. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 2000;43:1012-1019.
25. Sørensen H, Winzell MS, Brand CL, et al. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function. Diabetes 2006;55:3463-3469.
26. Gelling RW, Vuguin PM, Du XQ, et al. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass. Am J Physiol Endocrinol Metab 2009;297:E695-E707.
27. Lutz TA, Rand JS. Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques. J Comp Pathol 1997;116:157-170.
28. Palmer JP, Walter RM, Ensinck JW. Arginine-stimulated acute phase of insulin and glucagon secretion in normal man. Diabetes 1975;24:735-740.
29. Unger RH. Insulin-glucagon reltationships in the defense against hypoglycemia. Diabetes 1983;32:575-583.
30. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 2003;284:E671-E678.
31. Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 1985;28:574-578.
32. Unger RH. Role of glucagon in the pathogenesis of diabetes: The status of the controversy. Metabolism 1978;27:1691-1709.
33. Burcelin R, Katz EB, Charron MJ. Molecular and cellular aspects of the glucagon receptor: Role in diabetes and metabolism. Diabetes Metab 1996;22:373-396.
34. Marshall RD, Rand JS, Morton JM. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. J Feline Med Surg 2009;11:683-691.